Proopiomelanocortin gene expression and DNA methylation: Implications for Cushing's syndrome and beyond

Journal of Endocrinology

Volumn 177, Issue 3, 2003, Pages 365-372

  Newell Price, J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DNA; HOMEODOMAIN PROTEIN; MESSENGER RNA; PROOPIOMELANOCORTIN;

ADENOHYPOPHYSIS; CANCER CELL CULTURE; CORTICOTROPIN RELEASE; CPG ISLAND; CUSHING SYNDROME; DNA BINDING; DNA METHYLATION; DNA RESPONSIVE ELEMENT; ECTOPIC HORMONE PRODUCTION; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; LUNG SMALL CELL CANCER; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SATIETY; SIGNAL TRANSDUCTION;

ACTH SYNDROME, ECTOPIC; ANIMALS; CPG ISLANDS; CUSHING SYNDROME; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; HYPOTHALAMUS; NEOPLASMS; OBESITY; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS;

EID: 0037701826     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1770365     Document Type: Review

References (50)

1. Autelitano DJ, Lundblad JR, Blum M & Roberts JL 1989 Hormonal regulation of POMC gene expression. Annual Review of Physiology 51 715-726.
2. Bird A 1992 The essentials of DNA methylation. Cell 70 5-8.
3. Boyes J & Bird A 1992 Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO Journal 11 327-333.
4. Chen CL, Mather JP, Morris PL & Bardin CW 1984 Expression of pro-opiomelanocortin-like gene in the testis and epididymis. PNAS 81 5672-5675.
5. Chen CL, Chang CC, Krieger DT & Bardin CW 1986 Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: comparison with the testis. Endocrinology 118 2382-2389.
6. Choi YC & Chae CB 1991 DNA hypomethylation and germ cell-specific expression of testis-specific H2B histone gene. Journal of Biological Chemistry 266 20504-20511.
7. Choi YC, Gu W, Hecht NB, Feinberg AP & Chae CB 1996 Molecular cloning of mouse somatic and testis-specific H2B histone genes containing a methylated CpG island. DNA and Cell Biology 15 495-504.
8. Clark AJ, Lavender PM, Besser GM & Rees LH 1989 Pro-opiomelanocortin mRNA size heterogeneity in ACTH-dependent Cushing's syndrome. Journal of Molecular Endocrinology 2 3-9.
9. Clark AJ, Lavender PM, Coates P, Johnson MR & Rees LH 1990 In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA. Molecular Endocrinology 4 1737-1743.
10. Cochet M, Chang AC & Cohen SN 1982 Characterization of the structural gene and putative 5′-regulatory sequences for human proopiomelanocortin. Nature 297 335-339.
11. DeBold CR, Menefee JK, Nicholson WE & Orth DN 1988a Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. Molecular Endocrinology 2 862-870.
12. DeBold CR, Mufson EE, Menefee JK & Orth DN 1988b Proopiomelanocortin gene expression in a pheochromocytoma using upstream transcription initiation sites. Biochemical and Biophysical Research Communications 155 895-900.
13. De Smet C, Lurquin C, Lethe B, Martelange V & Boon T 1999 DNA methylation is the primary silencing mechanism for a set of germ line-specific and tumour-specific genes with a CpG rich promoter. Molecular and Cellular Biology 19 7327-7335.
14. Di Fiore B, Palena A, Felsani A, Palitti F, Caruso M & Lavia P 1999 Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2). Nucleic Acids Research 27 2852-2859.
15. Drouin J, Lamolet B, Lamonerie T, Lanctot C & Tremblay J 1998 The PTX family of homeodomain transcription factors during pituitary developments. Molecular and Cellular Endocrinology 140 31-36.
16. Evans CJ, Erdelyi E, Weber E & Barchas JD 1983 Identification of pro-opiomelanocortin-derived peptides in the human adrenal medulla. Science 221 957-960.
17. Ferguson-Smith AC, Sasaki H, Cattanach BM & Surani MA 1993 Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature 362 751-755.
18. Gardiner-Garden M & Frommer M 1987 CpG islands in vertebrate genomes. Journal of Molecular Biology 196 261-282.
19. Gardiner-Garden M & Frommer M 1994 Transcripts and CpG islands associated with the pro-opiomelanocortin gene and other neurally expressed genes. Journal of Molecular Endocrinology 12 365-382.
20. Gizang-Ginsberg E & Wolgemuth DJ 1985 Localization of mRNAs in mouse testes by in situ hybridization: distribution of alpha-tubulin and developmental stage specificity of pro-opiomelanocortin transcripts. Developmental Biology 111 293-305.
21. Hug M, Silke J, Georgiev O, Rusconi S, Schaffner W & Matsuo K 1996 Transcriptional repression by methylation: cooperativity between a CpG cluster in the promoter and remote CpG-rich regions. FEBS Letters 379 251-254.
22. de Keyzer Y, Bertagna X, Lenne F, Girard F, Luton JP & Kahn A 1985 Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries. Journal of Clinical Investigation 76 1892-1898.
23. de Keyzer Y, Bertagna X, Luton JP & Kahn A 1989 Variable modes of proopiomelanocortin gene transcription in human tumors. Molecular Endocrinology 3 215-223.
24. Kraus J, Buchfelder M & Hollt V 1993 Regulatory elements of the human proopiomelanocortin gene promoter. DNA and Cell Biology 12 527-536.
25. Lacaze-Masmonteil T, de Keyzer Y, Luton JP, Kahn A & Bertagna X 1987 Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. PNAS 84 7261-7265.
26. Lam EW & La Thangue NB 1994 DP and E2F proteins: coordinating transcription with cell cycle progression. Current Opinion in Cell Biology 6 859-866.
27. Lamolet B, Pulichino A, Lamonerie T, Gauthier Y, Brue T, Enjalbert A & Drouin J 2001 A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104 849-859.
28. Lamonerie T, Tremblay JJ, Lanctot C, Therrien M, Gauthier Y & Drouin J 1996 Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes and Development 10 1284-1295.
29. Lavender P, Clark AJ, Besser GM & Rees LH 1991 Variable methylation of the 5′-flanking DNA of the human pro-opiomelanocortin gene. Journal of Molecular Endocrinology 6 53-61.
30. Lolait SJ, Clements JA, Markwick AJ, Cheng C, McNally M, Smith AI & Funde JW 1986 Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. Journal of Clinical Investigation 77 1776-1779.
31. Macleod D, Charlton J, Mullins J & Bird AP 1994 Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes and Development 8 2282-2292.
32. Nan X, Campoy FJ & Bird A 1997 MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88 471-481.
33. Newell-Price J 2002 Surgery for Cushing's disease: following outcome and defining cure. Clinical Endocrinology 56 119-121.
34. Newell-Price J, Trainer P, Besser M & Grossman A 1998 The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews 19 647-672.
35. Newell-Price J, King P & Clark AJL 2000 DNA methylation and silencing of gene expression. Trends in Endocrinology 11 123-162.
36. Newell-Price J, King P & Clark AJ 2001 The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. Molecular Endocrinology 15 338-348.
37. Picon A, Leblond-Francillard M, Raffin-Sanson ML, Lenne F, Bertagna X & de Keyzer Y 1995 Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79. Journal of Molecular Endocrinology 15 187-194.
38. Picon A, Bertagna X & de Keyzer Y 1999 Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors. Oncogene 18 2627-2633.
39. Pintar JE, Schachter BS, Herman AB, Durgerian S & Krieger DT 1984 Characterization and localization of proopiomelanocortin messenger RNA in the adult rat testis. Science 225 632-634.
40. Poulin G, Turgeon B & Drouin J 1997 NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene. Molecular and Cell Biology 17 6673-6682.
41. Pritchard LE, Turnbull AV & White A 2002 Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. Journal of Endocrinology 172 411-421.
42. Riggs AD & Pfeifer GP 1992 X-chromosome inactivation and cell memory. Trends in Genetics 8 169-174.
43. Stoger R, Kubicka P, Liu CG, Kafri T, Razin A, Cedar H & Barlow DP 1993 Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 73 61-71.
44. Szeto DP, Rodriguez-Esteban C, Ryan AK, O'Connell SM, Liu F, Kioussi C, Gleiberman AS, Izpisua-Belmonte, JC & Rosenfeld MG 1999 Role of the bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes and Development 13 484-494.
45. Takahashi H, Teranishi Y, Nakanishi S & Numa S 1981 Isolation and structural organization of the human corticotropin-beta-lipotropin precursor gene. FEBS Letters 135 97-102.
46. Takahashi H, Hakamata Y, Watanabe Y, Kikuno R, Miyata T & Numa S 1983 Complete nucleotide, sequence of the human corticotropin-beta-lipotropin precursor gene. Nucleic Acids Research 11 6847-6858.
47. Therrien M & Drouin J 1991 Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements. Molecular and Cell Biology 11 3492-3503.
48. Therrien M & Drouin J 1993 Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Molecular and Cell Biology 13 2342-2353.
49. Tremblay JJ, Lanctot C & Drouin J 1998 The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Molecular Endocrinology 12 428-441.
50. Whitfeld PL, Seeburg PH & Shine J 1982 The human pro-opiomelanocortin gene: organization, sequence, and interspersion with repetitive DNA. DNA 1 133-143.